Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene

Clinical and Investigative Medicine

Volumn 21, Issue 6, 1998, Pages 251-257

  Kwan, Terry ^b   Leber, Brian ^b   Ahuja, Sonali ^b   Carter, Ronald ^b   Gerstein, Hertzel C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Department of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC MARKER; HEMOCHROMATOSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ADULT; CYSTEINE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; TYROSINE;

EID: 2042432325     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 1. Cartwright GE, Edwards CQ, Kravitz K, Skolnick M, Amos DB, Johnson A, et al. Hereditary hemochromatosis: phenotypic expression of the disease. N Engl J Med 1979;301:175-9.
2. 2. Niederau C, Stremmel W, Strohmeyer GWW. Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 1994;7:881-901.
3. 3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
4. 4. Mercier B, Mura C, Ferec C. Putting a hold on 'HLA-H'. Nat Genet 1997;15:234.
5. 5. Bodmer JG, Parham P, Albert ED, Marwsh SGE. Putting a hold on 'HLA-H'. Nat Genet 1997;15:234-5.
6. 6. Risch R. Haemochromatosis, HFE and genetic complexity. Nat Genet 1997;17:375-6.
7. 7. Jazwinska EC, Cullen LM, Busfield F. Haemochromatosis and HLA-H. Nat Genet 1996;14:249-51.
8. 8. Jouanolle AM, Gandon G, Jezequel P. Haemochromatosis and HLA-H. Nat Genet 1996;14:251-2.
9. 9. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. Hereditary hemochromatosis. Gene discovery and its implications for population-based screening (abstract). JAMA 1998;280:172-8.
10. 10. Niederau C, Rischer R, Sonnenberg A, Wolfgang S, Trampisch H, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
11. 11. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. Medicine 1955;34:381-430.
12. 12. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991;90:445-9.
13. 13. Phelps G, Hall P, Chapman I, Braund W, Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet 1989;8657:233-4.
14. 14. Singh BM, Grunewald RA, Press M, Muller BR, Wise PH. Prevalence of haemochromatosis amongst patients with diabetes mellitus. Diabet Med 1992;9:730-1.
15. 15. O'Brien T, Barren B, Murray DM, Dinneen S, O'Sullivan DJ. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabetes Care 1990;13:532-4.
16. 16. George DK, Evans RM, Crofton NA, Gunn TR. Testing for haemochromatosis in the diabetic clinic. Ann Clin Biochem 1995;32:521-6.
17. 17. Conte D, Manachino D, Colli A, Guala A, Aimo G, Andreoletti M, et al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med 1998;128:370-3.
18. 18. Adams P. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1995;45:146-9.
19. 19. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
20. 20. Nelson RL, Davis FG, Persky V, Backer E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995;76:875-9.
21. 21. Frayling T, Ellard S, Grove J, Walker M, Hattersley AT. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet 1998;351:1933-4.
22. 22. Merryweather-Clarke A, Pointon J, Shearman J, Robson K. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-9.
23. 23. Dineen SF, Silverberg JD, Batts KP, O'Brien PC, Ballard DJ, Rizza RA. Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc 1994;69:13-5.
24. 24. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentine A, Piperno A. Mutation anyalysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-32.
25. 25. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1997;22:187-94.
26. 26. Barton J, Shih W, Sawada-Hirai R, Acton R, Harmon L, Rivers C. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997;23:135-45.
27. 27. Willis G, Jennings B, Goodman E, Fellows I, Wimperis J. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis 1997;23:288-91.